Metraipolis › archive › dc_fde08f00b075

The Adjuvant-Phase Dilemma After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC: Evidence and Response-Guided Strategies — Europe PMC PMID:42794900

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794900
DOI
10.3390/cancers18182933
License (as archived)
solo-consultazione
Archived
2026-10-15T16:48:46.827Z
SHA-256 of the archived text
889ce1a30068b2f218c5a091e1822771360bebbf05957068e647be454542b60c
Stable URL of this page
https://metraipolis.com/documento/dc_fde08f00b075

How to cite

The Adjuvant-Phase Dilemma After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC: Evidence and Response-Guided Strategies — Europe PMC PMID:42794900 — Europe PMC (en), https://europepmc.org/article/MED/42794900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fde08f00b075 (Metraipolis archive dc_fde08f00b075, sha256 889ce1a30068b2f218c5a091e1822771360bebbf05957068e647be454542b60c)
BibTeX
@misc{dcfde08f00b075,
  title = {The Adjuvant-Phase Dilemma After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC: Evidence and Response-Guided Strategies — Europe PMC PMID:42794900},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794900},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fde08f00b075; sha256 889ce1a30068b2f218c5a091e1822771360bebbf05957068e647be454542b60c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794900. Agents can read the archived copy with the MCP tool read_document.